HOOD:NASDAQRobinhood Markets, Inc. Analysis
Data as of 2026-06-01 - not real-time
$90.73
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Robinhood (HOOD) is trading well above its short‑ and mid‑term moving averages while still lagging the long‑term average, indicating recent strength but a need for sustained upside to re‑align with its 200‑day trend. The RSI sits in the low‑to‑mid‑60s, suggesting solid momentum without being overbought, and the MACD remains bullish, reinforced by a rising volume trend. However, the DCF fair‑value estimate is substantially lower than the current market price, and a price‑to‑earnings multiple far exceeds both the industry average and the forward‑PE, flagging clear overvaluation. Recent news of the WonderFi acquisition and regulatory approvals for new brokerage services in Singapore and Canada provide a growth catalyst, expanding the platform’s geographic footprint and product suite. Despite these positives, the stock’s high beta, elevated 30‑day volatility, and historical drawdown depth amplify downside risk, especially in a sector sensitive to regulatory shifts. In summary, HOOD combines strong short‑term technical momentum and strategic expansion with a stretched valuation and pronounced risk profile, making the near‑term outlook cautiously optimistic but contingent on continued earnings growth and market sentiment.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Bullish MACD and supportive RSI momentum
- Increasing trading volume indicating heightened investor interest
- Technical price above short‑term averages despite long‑term lag
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Valuation premium relative to DCF and peers
- Potential earnings uplift from WonderFi integration
- Elevated beta and volatility that could temper price appreciation
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Strategic expansion into Canada and Singapore broadening addressable market
- Strong operating margins and high ROE supporting sustainable profitability
- Long‑term growth narrative outweighing current overvaluation if execution succeeds
Key Metrics & Analysis
Financial Health
Revenue Growth15.10%
Profit Margin41.12%
P/E Ratio44.0
ROE21.46%
ROA5.19%
Debt/Equity140.48
P/B Ratio8.8
Op. Cash Flow$3.0B
Industry P/E16.6
Technical Analysis
TrendNeutral
RSI63.5
Support$73.18
Resistance$94.40
MA 20$78.82
MA 50$77.11
MA 200$103.82
MACDBullish
VolumeIncreasing
Fear & Greed Index92.77
Valuation
Fair Value$64.77
Target Price$98.77
Upside/Downside8.86%
GradeOvervalued
TypeGrowth
Risk Assessment
Beta3.27
Volatility76.91%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.